Literature DB >> 362214

Dobutamine: a new synthetic cardioactive sympathetic amine.

E H Sonnenblick, W H Frishman, T H LeJemtel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 362214     DOI: 10.1056/NEJM197901043000105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs.

Authors:  A Dorszewski; B Müller-Beckmann; L Kling; G Sponer
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Strengthening the heartbeat.

Authors: 
Journal:  Br Med J       Date:  1979-07-21

4.  Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training.

Authors:  C Liang; R R Tuttle; W B Hood; H Gavras
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

Review 5.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

6.  Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

Authors:  A C Tweddel; R G Murray; D Pearson; W Martin; I Hutton
Journal:  Br Heart J       Date:  1982-04

7.  Effect of dobutamine on left ventricular relaxation and filling phase in patients with ischemic heart disease and preserved systolic function.

Authors:  R Zeppellini; R Bolognesi; A Javernaro; R De Domenico; M Libardoni; D Tsialtas; D Piovan; R Padrini; F Cucchini
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

8.  Differential effects of (+/-)-dobutamine and human alpha-CGRP on cardiac and on regional haemodynamics in conscious Long Evans rats.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett; B Hughes; R Foulkes
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Comparison of the cardiodynamic and metabolic effects of dobutamine with those of norepinephrine and dopamine in the dog isolated heart.

Authors:  J A Simaan; G Fawaz; K Jabbour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

Review 10.  Structures reveal details of small molecule binding to cardiac troponin.

Authors:  Fangze Cai; Monica X Li; Sandra E Pineda-Sanabria; Shorena Gelozia; Steffen Lindert; Frederick West; Brian D Sykes; Peter M Hwang
Journal:  J Mol Cell Cardiol       Date:  2016-11-05       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.